So, the goal of the current study is to analyze the expression pattern of TPD52, KLF3, miR-124, and PKCε in breast cancer patients as well as to predict their possible correlation with clinicopathological characteristics of breast cancer. Here, PRKCE is linked to breast carcinoma.